Ghost Tree Capital as of June 30, 2023
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 57 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Ser Tr S&p Biotech Call Option (XBI) | 8.2 | $25M | 300k | 83.20 | |
| Tg Therapeutics (TGTX) | 6.8 | $21M | 825k | 24.84 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 5.6 | $17M | 330k | 51.00 | |
| Akero Therapeutics (AKRO) | 5.5 | $17M | 360k | 46.69 | |
| Apellis Pharmaceuticals (APLS) | 5.4 | $16M | 180k | 91.10 | |
| Vaxcyte (PCVX) | 4.6 | $14M | 280k | 49.94 | |
| Revance Therapeutics (RVNC) | 4.4 | $13M | 525k | 25.31 | |
| Madrigal Pharmaceuticals (MDGL) | 4.2 | $13M | 55k | 231.00 | |
| Amylyx Pharmaceuticals (AMLX) | 3.9 | $12M | 550k | 21.57 | |
| Viking Therapeutics (VKTX) | 3.5 | $11M | 650k | 16.21 | |
| Sarepta Therapeutics (SRPT) | 3.2 | $9.7M | 85k | 114.52 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 2.9 | $8.9M | 100k | 89.25 | |
| Reata Pharmaceuticals Cl A | 2.9 | $8.7M | 85k | 101.96 | |
| Axsome Therapeutics (AXSM) | 2.6 | $7.9M | 110k | 71.86 | |
| Syndax Pharmaceuticals (SNDX) | 2.4 | $7.3M | 350k | 20.93 | |
| Mirati Therapeutics | 2.4 | $7.2M | 200k | 36.13 | |
| Xenon Pharmaceuticals (XENE) | 2.4 | $7.1M | 185k | 38.50 | |
| Cogent Biosciences (COGT) | 2.2 | $6.8M | 575k | 11.84 | |
| Protagonist Therapeutics (PTGX) | 2.1 | $6.2M | 225k | 27.62 | |
| Miragen Therapeutics (VRDN) | 1.9 | $5.7M | 240k | 23.79 | |
| Biomea Fusion (BMEA) | 1.4 | $4.2M | 190k | 21.95 | |
| Incyte Corporation (INCY) | 1.3 | $4.0M | 65k | 62.25 | |
| Beigene Sponsored Adr | 1.3 | $4.0M | 23k | 178.30 | |
| Ambrx Biopharma Sponsored Ads | 1.3 | $3.9M | 238k | 16.46 | |
| Vir Biotechnology (VIR) | 1.2 | $3.7M | 150k | 24.53 | |
| Alpine Immune Sciences | 1.2 | $3.6M | 347k | 10.28 | |
| Aerovate Therapeutics (AVTE) | 1.1 | $3.5M | 201k | 17.15 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.9 | $2.8M | 100k | 28.21 | |
| Karuna Therapeutics Ord | 0.9 | $2.7M | 13k | 216.85 | |
| Tarsus Pharmaceuticals (TARS) | 0.9 | $2.7M | 150k | 18.07 | |
| Amicus Therapeutics (FOLD) | 0.8 | $2.5M | 200k | 12.56 | |
| Astria Therapeutics (ATXS) | 0.8 | $2.5M | 300k | 8.33 | |
| Uniqure Nv SHS (QURE) | 0.8 | $2.5M | 215k | 11.46 | |
| Krystal Biotech (KRYS) | 0.8 | $2.3M | 20k | 117.40 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.8 | $2.3M | 110k | 21.14 | |
| Phathom Pharmaceuticals (PHAT) | 0.7 | $2.2M | 154k | 14.32 | |
| Fusion Pharmaceuticals | 0.6 | $1.9M | 413k | 4.67 | |
| ImmunoGen | 0.6 | $1.9M | 100k | 18.87 | |
| Pmv Pharmaceuticals (PMVP) | 0.6 | $1.8M | 281k | 6.26 | |
| Aadi Bioscience (AADI) | 0.6 | $1.7M | 250k | 6.84 | |
| Arcus Biosciences Incorporated (RCUS) | 0.5 | $1.5M | 75k | 20.31 | |
| Rocket Pharmaceuticals (RCKT) | 0.5 | $1.5M | 75k | 19.87 | |
| BioCryst Pharmaceuticals (BCRX) | 0.5 | $1.4M | 200k | 7.04 | |
| Morphic Hldg (MORF) | 0.4 | $1.1M | 20k | 57.33 | |
| Inhibrx | 0.3 | $909k | 35k | 25.96 | |
| Bioxcel Therapeutics Call Option (BTAI) | 0.3 | $866k | 130k | 6.66 | |
| Springworks Therapeutics (SWTX) | 0.2 | $723k | 28k | 26.22 | |
| Bridgebio Pharma (BBIO) | 0.2 | $722k | 42k | 17.20 | |
| Avidity Biosciences Ord (RNA) | 0.2 | $721k | 65k | 11.09 | |
| Iovance Biotherapeutics (IOVA) | 0.2 | $704k | 100k | 7.04 | |
| Ptc Therapeutics I (PTCT) | 0.2 | $678k | 17k | 40.67 | |
| Roivant Sciences SHS (ROIV) | 0.2 | $645k | 64k | 10.08 | |
| Rain Therapeutics | 0.1 | $390k | 325k | 1.20 | |
| Replimune Group (REPL) | 0.1 | $252k | 11k | 23.22 | |
| Vanda Pharmaceuticals (VNDA) | 0.1 | $204k | 31k | 6.59 | |
| Mersana Therapeutics (MRSN) | 0.1 | $202k | 61k | 3.29 | |
| Fibrogen (FGEN) | 0.0 | $99k | 37k | 2.70 |
